Market Cap 3.7B 984M 851M 800M 728M 1.37B 93.91B 1.39B 9.37B 3.67B 47.11B 3.61B 157B P/E 2026 *
19.1x
P/E 2027 * 14.8x
Enterprise Value 4.71B 1.25B 1.08B 1.02B 927M 1.74B 120B 1.77B 11.93B 4.67B 60.01B 4.6B 200B EV / Sales 2026 *
2.51x
EV / Sales 2027 * 2.37x
Free-Float
78.97%
Yield 2026 *
1.73%
Yield 2027 * 3.22%
1 day+0.52%
1 week-1.53%
Current month-1.09%
1 month+2.31%
3 months+4.10%
6 months+5.59%
Current year+18.80%
1 week 30.6
Extreme 30.6
31.6
1 month 28.6
Extreme 28.6
32
Current year 24.96
Extreme 24.96
33.12
1 year 24.96
Extreme 24.96
33.12
3 years 20.94
Extreme 20.94
42.85
5 years 20.94
Extreme 20.94
55.8
10 years 20.94
Extreme 20.94
61.4
Manager TitleAgeSince
Chief Executive Officer 58 04/01/2021
Chief Executive Officer - 06/04/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 02/04/2016
Director/Board Member - 02/04/2019
Director/Board Member - 02/04/2019
Change 5-day change 1-year change 3-year change Capi.($)
+0.52%-1.53%+18.71%-18.74% 984M
-2.25%-0.99%+78.68%+123.40% 1,078B
-0.66%+1.31%+49.27%+49.76% 632B
-0.54%+2.29%+23.82%+63.92% 443B
-1.99%-2.63%+42.21%+33.92% 356B
-1.05%-2.19%+25.55%+34.88% 289B
-2.12%-3.29%+0.14%+3.90% 245B
-0.63%+2.56%+43.51%+58.17% 226B
-1.19%+0.37%-9.57%-52.51% 204B
+0.16%+5.73%+15.17%+72.95% 171B
Average -0.63%+1.07%+28.75%+36.96% 364.47B
Weighted average by Cap. -0.35%+1.30%+43.74%+63.32%

Financials

2026 *2027 *
Net sales 1.88B 500M 432M 407M 370M 694M 47.71B 706M 4.76B 1.86B 23.93B 1.84B 79.65B 1.92B 513M 443M 417M 379M 711M 48.91B 724M 4.88B 1.91B 24.54B 1.88B 81.67B
Net income 195M 51.91M 44.89M 42.21M 38.39M 72.02M 4.95B 73.32M 494M 193M 2.48B 191M 8.27B 253M 67.37M 58.25M 54.77M 49.83M 93.46M 6.43B 95.14M 641M 251M 3.22B 247M 10.73B
Net Debt 1.01B 270M 233M 219M 199M 374M 25.73B 381M 2.57B 1B 12.9B 990M 42.95B 863M 230M 199M 187M 170M 319M 21.93B 325M 2.19B 856M 11B 844M 36.61B
Logo Saudi Pharmaceutical Industries and Medical Appliances Corporation
Saudi Pharmaceutical Industries and Medical Appliances Corp SPIMACO ADDWAEIH SJSC is a Saudi Arabia based pharmaceutical company. The Company is primarily engaged in manufacturing of pharmaceutical products, medicines for human use and wholesale and retail of medicines and related products, development and marketing of medical and pharmaceutical products, research and development in medical science activities, operating and maintaining the healthcare facilities and any investments in related industries. The Company is organized into four segments which include Pharmaceutical Manufacturing, Trading and Distribution Services, Healthcare Services and Discontinued Operation. Products of the Company include tablets, capsules, syrups and suspensions, injections, creams, ointments and gels, suppositories, mouthwash and antiseptic products. The Subsidiaries of the Company include ARACOM Medical Company, Dammam Pharmaceutical Company, SPIMACO Misr Company for Distribution and others.
Employees
-
Date Price Change Volume
13/08/26 SAR 30.96 +0.52% 202,399
12/08/26 SAR 30.80 -0.58% 188,368
11/08/26 SAR 30.98 -1.46% 243,208
10/08/26 SAR 31.44 +1.55% 219,438
09/08/26 SAR 30.96 -1.53% 239,927
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
30.96SAR
Average target price
31.86SAR
Spread / Average Target
+2.92%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2070 Stock